ALG11

gene product
CDG1P, KIAA0266
This gene encodes a GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase which is localized to the cytosolic side of the endoplasmic reticulum (ER) and catalyzes the transfer of the fourth and fifth mannose residue from GDP-mannose (GDP-Man) to Man3GlcNAc2-PP-dolichol and Man4GlcNAc2-PP-dolichol resulting in the production of Man5GlcNAc2-PP-dolichol. Mutations in this gene are associated with congenital disorder of glycosylation type Ip (CDGIP). This gene overlaps but is distinct from the UTP14, U3 small nucleolar ribonucleoprotein, homolog C (yeast) gene. A pseudogene of the GDP-Man:Man3GlcNAc2-PP-dolichol-alpha1,2-mannosyltransferase has been identified on chromosome 19. [provided by RefSeq, Aug 2010]
More gene data

Featured antibodies

Antibodies

 

Filters

Application

Antibodypedia Validation Initiative

Validation method

Reference

Provider

Host

Reactivity

Antibody type

Conjugate

Antibody

  or   Clear
Enhanced validation
Enhanced validation
Supportive data in Antibodypedia
Data presented on provider website
Data in Antibodypedia (inconclusive)
Validated within AVI
Eligible for validation within AVI
208 antibodies from 18 providers.

Antibody properties

General

Applications

or Cancel
Antibody
antibodies-online
84 antibodies
LifeSpan BioSciences, Inc.
39 antibodies
Aviva Systems Biology
4 antibodies
OriGene
4 antibodies
Novus Biologicals
3 antibodies
Biorbyt
13 antibodies
GeneTex
2 antibodies
Invitrogen Antibodies
2 antibodies
ProSci
4 antibodies
Proteintech Group
1 antibody
Abnova Corporation
1 antibody
Acris Antibodies GmbH
1 antibody
Atlas Antibodies
1 antibody
MyBioSource
3 antibodies
Abbexa
6 antibodies
United States Biological
26 antibodies
Creative Diagnostics
2 antibodies